Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3,4-epoxybutyl-alpha-D-glucopyranoside
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
3,4-Epoxybutyl-alpha-D-glucopyranoside is a synthetic glycoside in which a glucose moiety is linked via an O-glycosidic bond to a 3',4'-epoxybutyl group. It is classified as an experimental small molecule and has not been approved for clinical use. The compound has been studied primarily as a chemical probe and inhibitor of beta-amylase enzymes. Structural studies have shown that it can act as both a reversible and irreversible inhibitor of barley beta-amylase by covalently modifying the enzyme's catalytic residues[9][1][3]. Its main application has been in biochemical research to dissect starch degradation pathways in plants.
- Other names
- 3,4-EPOXYBUTYL-alpha-D-glucopyranoside(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(2-((2S)-oxiran-2-yl)ethoxy)oxane-3,4,5-triol(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{2-[(2S)-oxiran-2-yl]ethoxy}oxane-3,4,5-triol2-hydroxymethyl-6-(2-Oxiranyl-Ethoxy)-tetrahydro-pyran-3,4,5-triol
Beyond the preview
Go deeper on 3,4-epoxybutyl-alpha-D-glucopyranoside.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3,4-epoxybutyl-alpha-D-glucopyranoside.